Telehealth platform Hims & Hers will cut about 4% of its workforce, as it adjusts to a U.S. ban on manufacturing mass copies of the weight-loss drug Wegovy.
Related Posts
S&P 500 futures are little changed as Wall Street looks to Fed policy meeting: Live updates
The S&P 500 ended a nine-day winning run on Monday as the major averages slid.
Social Security’s retirement trust fund may run out in nine years. Here’s how the next U.S. president may address that
The trust fund that Social Security relies on to pay retirement benefits may be depleted in nine years. How the next U.S. president could change […]
Slower economic growth is likely ahead with risk of a recession rising, according to the CNBC Fed Survey
The 32 survey respondents, who include fund managers, strategists and analysts, raised the probability of recession to 36% from 23% in January.